altimmune glp 1 Altimmune, Inc. Announces Presentation of IMPACT Phase 2b Study Results at EASL Congress 2026, Highlighting Efficacy and Safety Data for Pemvidutide in MASH Altimmune CEO on what's next
Pay in 4 interest-free payments of $5.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



























